Impact of high-dose chemotherapy and autologous transplantation as first-line therapy on the survival of high-risk diffuse large B cell lymphoma patients: a single-center study in Japan

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

Christian Gisselbrecht, Nicolas Mounier, Devinder Gill et al. · Journal of Clinical Oncology · 2010 · 1.6K citations · Full text

Medicine, Oncology, Chemotherapy +13

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai et al. · Blood · 2006 · 1.5K citations

Medicine, Hematology, Oncology +5

Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20⁺B-Cell Lymphoma in the Rituximab Era

Marita Ziepert, Dirk Hasenclever, Evelyn Kuhnt et al. · Journal of Clinical Oncology · 2010 · 585 citations · Full text

Medicine, Immunology, Oncology +13

Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study

Corinne Haïoun, Éric Lepage, Christian Gisselbrecht et al. · Journal of Clinical Oncology · 2000 · 422 citations

Medicine, Oncology, Chemotherapy +15

Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

Nöel Milpied, Éric Deconinck, Fanny Gaillard et al. · New England Journal of Medicine · 2004 · 341 citations · Full text

Medicine, Hematology, Oncology +13